176 related articles for article (PubMed ID: 16622209)
1. A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1.
Nogueira PA; Alves FP; Fernandez-Becerra C; Pein O; Santos NR; Pereira da Silva LH; Camargo EP; del Portillo HA
Infect Immun; 2006 May; 74(5):2726-33. PubMed ID: 16622209
[TBL] [Abstract][Full Text] [Related]
2. Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay.
Fernandez-Becerra C; Sanz S; Brucet M; Stanisic DI; Alves FP; Camargo EP; Alonso PL; Mueller I; del Portillo HA
Malar J; 2010 Jan; 9():29. PubMed ID: 20092651
[TBL] [Abstract][Full Text] [Related]
3. Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil.
Soares IS; Oliveira SG; Souza JM; Rodrigues MM
Acta Trop; 1999 Jan; 72(1):13-24. PubMed ID: 9924957
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1.
Pandey JP; Morais CG; Fontes CJ; Braga EM
Malar J; 2010 Aug; 9():229. PubMed ID: 20696056
[TBL] [Abstract][Full Text] [Related]
5. Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.
Wang Q; Zhao Z; Zhang X; Li X; Zhu M; Li P; Yang Z; Wang Y; Yan G; Shang H; Cao Y; Fan Q; Cui L
PLoS One; 2016; 11(3):e0151900. PubMed ID: 26999435
[TBL] [Abstract][Full Text] [Related]
6. Malaria transmission and individual variability of the naturally acquired IgG antibody against the Plasmodium vivax blood-stage antigen in an endemic area in Brazil.
Costa EMF; Amador ECC; Silva ES; Alvarenga CO; Pereira PE; Póvoa MM; Cunha MG
Acta Trop; 2020 Sep; 209():105537. PubMed ID: 32454033
[TBL] [Abstract][Full Text] [Related]
7. Analysis of naturally acquired antibody responses to the 19-kd C-terminal region of merozoite surface protein-1 of Plasmodium vivax from individuals in Sanliurfa, Turkey.
Zeyrek FY; Babaoglu A; Demirel S; Erdogan DD; Ak M; Korkmaz M; Coban C
Am J Trop Med Hyg; 2008 May; 78(5):729-32. PubMed ID: 18458304
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal study of naturally acquired humoral immune responses against the merozoite surface protein 1 of Plasmodium vivax in patients from Rondonia, Brazil.
Mertens F; Levitus G; Camargo LM; Ferreira MU; Dutra AP; Del Portillo HA
Am J Trop Med Hyg; 1993 Sep; 49(3):383-92. PubMed ID: 8372960
[TBL] [Abstract][Full Text] [Related]
9. High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms.
Versiani FG; Almeida ME; Melo GC; Versiani FO; Orlandi PP; Mariúba LA; Soares LA; Souza LP; da Silva Balieiro AA; Monteiro WM; Costa FT; del Portillo HA; Lacerda MV; Nogueira PA
Malar J; 2013 Aug; 12():294. PubMed ID: 23977965
[TBL] [Abstract][Full Text] [Related]
10. The Plasmodium vivax merozoite surface protein 1 paralog is a novel erythrocyte-binding ligand of P. vivax.
Cheng Y; Wang Y; Ito D; Kong DH; Ha KS; Chen JH; Lu F; Li J; Wang B; Takashima E; Sattabongkot J; Tsuboi T; Han ET
Infect Immun; 2013 May; 81(5):1585-95. PubMed ID: 23460511
[TBL] [Abstract][Full Text] [Related]
11. N-terminal Plasmodium vivax merozoite surface protein-1, a potential subunit for malaria vivax vaccine.
Versiani FG; Almeida ME; Mariuba LA; Orlandi PP; Nogueira PA
Clin Dev Immunol; 2013; 2013():965841. PubMed ID: 24187566
[TBL] [Abstract][Full Text] [Related]
12. Cellular and humoral immune responses against the Plasmodium vivax MSP-1₁₉ malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of Brazil.
Riccio EK; Totino PR; Pratt-Riccio LR; Ennes-Vidal V; Soares IS; Rodrigues MM; de Souza JM; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
Malar J; 2013 Sep; 12():326. PubMed ID: 24041406
[TBL] [Abstract][Full Text] [Related]
13. Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria.
Soares IS; Levitus G; Souza JM; Del Portillo HA; Rodrigues MM
Infect Immun; 1997 May; 65(5):1606-14. PubMed ID: 9125537
[TBL] [Abstract][Full Text] [Related]
14. Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant.
Yang C; Collins WE; Sullivan JS; Kaslow DC; Xiao L; Lal AA
Infect Immun; 1999 Jan; 67(1):342-9. PubMed ID: 9864235
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
[TBL] [Abstract][Full Text] [Related]
16. Naturally acquired immune responses to P. vivax merozoite surface protein 3α and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean children.
Stanisic DI; Javati S; Kiniboro B; Lin E; Jiang J; Singh B; Meyer EV; Siba P; Koepfli C; Felger I; Galinski MR; Mueller I
PLoS Negl Trop Dis; 2013 Nov; 7(11):e2498. PubMed ID: 24244763
[TBL] [Abstract][Full Text] [Related]
17. Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1₁₉ and PvMSP-3α₃₅₉₋₇₉₈ and their relationship with hematological features in malaria patients from the Brazilian Amazon.
Mourão LC; Morais CG; Bueno LL; Jimenez MC; Soares IS; Fontes CJ; Guimarães Lacerda MV; Xavier MS; Barnwell JW; Galinski MR; Braga EM
Microbes Infect; 2012 Aug; 14(9):730-9. PubMed ID: 22445906
[TBL] [Abstract][Full Text] [Related]
18. Soluble recombinant merozoite surface antigen-142kDa of Plasmodium vivax: An improved diagnostic antigen for vivax malaria.
Mirahmadi H; Fallahi S; Seyyed Tabaei SJ
J Microbiol Methods; 2016 Apr; 123():44-50. PubMed ID: 26851675
[TBL] [Abstract][Full Text] [Related]
19. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran.
Mehrizi AA; Zakeri S; Salmanian AH; Sanati MH; Djadid ND
Acta Trop; 2009 Oct; 112(1):1-7. PubMed ID: 19481997
[TBL] [Abstract][Full Text] [Related]
20. A Chimeric Plasmodium vivax Merozoite Surface Protein Antibody Recognizes and Blocks Erythrocytic P. cynomolgi Berok Merozoites
Shen FH; Ong JJY; Sun YF; Lei Y; Chu RL; Kassegne K; Fu HT; Jin C; Han ET; Russell B; Han JH; Cheng Y
Infect Immun; 2021 Jan; 89(2):. PubMed ID: 33199351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
